Patents by Inventor Vaseem A. PALEJWALA

Vaseem A. PALEJWALA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NASAL FORMULATIONS OF FORALUMAB
    Publication number: 20230365689
    Abstract: This invention relates to therapeutic, diagnostic and/or prophylactic formulations and dosages and dosing regimens of anti-CD3 antibodies, as well as to methods for using such formulations and dosages and dosing regimens.
    Type: Application
    Filed: May 15, 2023
    Publication date: November 16, 2023
    Inventors: Jules S. JACOB, Vaseem A. PALEJWALA, Kunwar SHAILUBHAI
  • SUBCUTANEOUS ADMINISTRATION OF ANTIBODIES FOR THE TREATMENT OF DISEASE
    Publication number: 20220332822
    Abstract: This invention provides methods of subcutaneous administration of anti-CD3 monoclonal antibodies (mAbs) either alone or in combination with monoclonal antibodies, that recognize the Interleukin-6 (IL-6) and IL-6 receptor (IL-6R) complex for the treatment, prevention or alleviating a symptom of a disease.
    Type: Application
    Filed: April 18, 2022
    Publication date: October 20, 2022
    Inventors: Kunwar SHAILUBHAI, Vaseem A. PALEJWALA, Jules S. JACOB
  • COMPOSITIONS OF IL-6/IL-6R ANTIBODIES AND METHODS OF USE THEREOF
    Publication number: 20210284743
    Abstract: The present disclosure provides compositions and methods for the treatment of coronavirus infections, such as SAR-CoV, SARS-CoV-2, and MERS-CoV. The compositions include antibodies targeting the IL-6 receptor complex, antibodies targeting CD3, dactinomycin, and combinations thereof. The methods of treatment include administration of antibodies and combination therapies to reduce or eliminate symptoms associated with coronavirus infection or pulmonary inflammatory disease.
    Type: Application
    Filed: March 10, 2021
    Publication date: September 16, 2021
    Inventors: Kunwar SHAILUBHAI, Gabriele CERRONE, Vaseem A. PALEJWALA, Jules S. JACOB
  • AGONISTS OF GUANYLATE CYCLASE USEFUL FOR THE TREATMENT OF OPIOID INDUCED DYSFUNCTIONS
    Publication number: 20200330548
    Abstract: This invention provides a method to prevent, control, and/or treat opioid induced dysfunctions comprising administering to a patient in need a guanylate cyclase receptor agonist (GCRA) peptide. Compositions comprising guanylate cyclase receptor agonist (GCRA) peptides, methods of making, and methods of treatment are also disclosed.
    Type: Application
    Filed: May 14, 2020
    Publication date: October 22, 2020
    Inventors: Kunwar SHAILUBHAI, Vaseem PALEJWALA
  • COMPOSITIONS AND METHOD FOR THE TREATMENT AND DETECTION OF COLON CANCER
    Publication number: 20200023080
    Abstract: The present invention provides methods of detecting and treating colon cancer using conjugates comprising a GCRA peptide and one or more components such as a drug delivery vehicle, a chemotherapeutic agent, a micelle, a nanoparticle, a liposome, a polymer, a lipid, an imaging agent, and a labeling agent.
    Type: Application
    Filed: November 18, 2016
    Publication date: January 23, 2020
    Inventors: Kunwar SHAILUBHAI, Vaseem PALEJWALA
  • AGONISTS OF GUANYLATE CYCLASE USEFUL FOR THE TREATMENT OF OPIOID INDUCED DYSFUNCTIONS
    Publication number: 20200009215
    Abstract: This invention provides a method to prevent, control, and/or treat opioid induced dysfunctions comprising administering to a patient in need a guanylate cyclase receptor agonist (GCRA) peptide. Compositions comprising guanylate cyclase receptor agonist (GCRA) peptides, methods of making, and methods of treatment are also disclosed.
    Type: Application
    Filed: September 20, 2019
    Publication date: January 9, 2020
    Inventors: Kunwar SHAILUBHAI, Vaseem PALEJWALA
  • AGONISTS OF GUANYLATE CYCLASE USEFUL FOR THE TREATMENT OF OPIOID INDUCED DYSFUNCTIONS
    Publication number: 20160367622
    Abstract: This invention provides a method to prevent, control, and/or treat opioid induced dysfunctions comprising administering to a patient in need a guanylate cyclase receptor agonist (GCRA) peptide. Compositions comprising guanylate cyclase receptor agonist (GCRA) peptides, methods of making, and methods of treatment are also disclosed.
    Type: Application
    Filed: November 18, 2015
    Publication date: December 22, 2016
    Inventors: Kunwar SHAILUBHAI, Vaseem PALEJWALA
  • AGONISTS OF GUANYLATE CYCLASE USEFUL FOR THE TREATMENT OF OPIOID INDUCED DYSFUNCTIONS
    Publication number: 20160220630
    Abstract: The disclosure provides a method to prevent, control, and/or treat opioid induced dysfunctions comprising administering to a patient in need a guanylate cyclase receptor agonist (GCRA) peptide. Compositions comprising guanylate cyclase receptor agonist (GCRA) peptides, methods of making, and methods of treatment are also disclosed. Further disclosed are the guanylate cyclase receptor agonist (GCRA) peptide and opioid formulated in the same composition.
    Type: Application
    Filed: October 10, 2014
    Publication date: August 4, 2016
    Inventors: Kunwar SHAILUBHAI, Vaseem PALEJWALA
  • Use of cathepsin z inhibitors for the treatment of rhuematoid arthritis and other autoimmune diseases
    Publication number: 20070155650
    Abstract: Methods for identifying compounds for treating autoimmune diseases including rheumatoid arthritis. Compounds for treating autoimmune diseases including rheumatoid arthritis. Methods of treatment for autoimmune diseases including rheumatoid arthritis. These methods and compounds are directed to inhibiting the activity of Cathepsin Z.
    Type: Application
    Filed: December 14, 2004
    Publication date: July 5, 2007
    Applicant: AVENTIS PHARMACEUTICALS INC.
    Inventors: Alan Saltzman, Zhihua Tang, Vaseem Palejwala, Jean Cavallo